SIGHT SCIENCES, INC. conducted a cost-utility analysis in the US in July 2025.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
SIGHT SCIENCES, INC. conducted a cost-utility analysis in the US in July 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- SIGHT SCIENCES, INC. confirmed it was operating within the US market as of June 25, 2025.Sub-event
The company performed a cost-utility analysis in the US.1 source
Keep exploring
The entities involved
-
SIGHT SCIENCES, INC.
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireSight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gl